Send Inquiry

Request To Call Back

Erythropoietin Injection I.P

Get a Price/Quote

MOQ : 100 Packs

Erythropoietin Injection I.P Specification

Brand Name
Erythropoietin Injection I.P.

Salt Composition
Erythropoietin Alfa (Recombinant)

Origin of Medicine
India

Indication
Anemia due to chronic renal failure, chemotherapy-induced anemia, HIV-induced anemia

Pacakaging (Quantity Per Box)
1 prefilled syringe per box

Packaging Type
Prefilled syringe in sterile pack

Dosage Form
Injection

Life Span
24 months from manufacturing date

Drug Type
Biological/Erythropoiesis-Stimulating Agent

Ingredients
Erythropoietin (Recombinant Human Erythropoietin Alfa)

Physical Form
Liquid Solution

Function
Stimulates red blood cell production

Recommended For
Patients with anemia, particularly due to chronic kidney disease or chemotherapy

Dosage
Varies as per physicians instruction, typically administered subcutaneously or intravenously

Dosage Guidelines
Use as directed by the physician

Suitable For
Adults and children under medical supervision

Quantity
4000 IU/ml, 1 ml per prefilled syringe

Storage Instructions
Store at 2C - 8C. Do not freeze. Protect from light.

Contraindications
Uncontrolled hypertension, hypersensitivity to mammalian cell-derived products

Common Side Effects
Hypertension, headache, injection site reactions, flu-like symptoms

Manufacturing License
Complies with Indian Drug Authority regulations

Caution
Not for self-administration; for use by healthcare professionals only

Batch Number
Provided on the pack

Shelf Life After Opening
Use immediately after opening

Regulatory Approval
CDSCO (India) approved

Prescription/Non-Prescription
Prescription

Therapeutic Class
Hematopoietic Agents

Route of Administration
Subcutaneous or Intravenous

Intended Use
For hospital and clinical use only

Appearance
Clear, colorless solution

Marketed By
As per manufacturer listed

Erythropoietin Injection I.P Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Erythropoietin Injection I.P

Discover the Trending Erythropoietin Injection I.P., now at a Reduced Price for eligible institutions. This pristine hematopoietic agent, presented as a clear, colorless, and ravishing solution, is a highlighted choice for anemia management in adults and children under strict medical supervision. Administered subcutaneously or intravenously, its imposing efficacy is underpinned by CDSCO approval and compliance with Indian Drug Authority requirements. Exclusively for hospital or clinical use, each sterile prefilled syringe contains 4000 IU/ml of recombinant erythropoietin alfa, ideal for patients battling anemia due to chronic kidney disease, chemotherapy, or HIV.

Key Clinical Features and Professional Usage

Erythropoietin Injection I.P. is widely used by healthcare professionals in hospital and clinical settings, targeting anemia in patients with chronic renal failure, those undergoing chemotherapy, or HIV therapy. Its specific usage requires careful dose adjustment as prescribed by a physician and is strictly for administration by trained personnel only, never for self-use. The product boasts a shelf life of 24 months, with robust regulatory approval, and should be used immediately once opened to maintain its pristine effectiveness.

Delivery Timelines and Packaging Exchange Details

We offer prompt handover of Erythropoietin Injection I.P., typically within 2-5 business days, depending on location and availability. Samples may be available for evaluation upon request, supporting facilities in making informed choices. Each exchange consists of securely packaged, sterile prefilled syringes-one per box-ensuring integrity upon arrival. Our supplier network stands ready to offer smooth transactions and reliable delivery for all hospital or clinical requirements.

FAQ's of Erythropoietin Injection I.P:

Q: How should Erythropoietin Injection I.P. be administered?

A: Erythropoietin Injection I.P. should only be administered subcutaneously or intravenously by a qualified healthcare professional, as per the physician's specific instructions.

Q: What are the primary indications for using this product?

A: This injection is indicated for treating anemia caused by chronic renal failure, chemotherapy, or HIV infection, and should be used strictly in hospital or clinical environments.

Q: When should the solution be used after opening the packaging?

A: Once opened, the prefilled syringe must be used immediately to maintain its pristine quality and effectiveness.

Q: Where can I access Erythropoietin Injection I.P.?

A: Erythropoietin Injection I.P. is available for purchase by registered hospitals, clinics, and healthcare facilities across India, as supplied by licensed traders and suppliers.

Q: What are the common side effects associated with its use?

A: Common side effects may include hypertension, headache, injection site reactions, and flu-like symptoms. Patients should be monitored by healthcare professionals during treatment.

Q: How does Erythropoietin Injection I.P. benefit patients?

A: The injection helps stimulate red blood cell production, alleviating anemia and improving the overall quality of life in patients with chronic kidney disease, chemotherapy-induced anemia, or HIV-induced anemia.

Tell us about your requirement